Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018
Experimental Dermatology · 2023
DOI: 10.1111/exd.14770 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Dermatology, 2023. Verfasst von Xin Yun Teoh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Queen Elizabeth, Ministry of Health Malaysia, Kota Kinabalu, Malaysia. Hauptthemen laut MEDLINE: Psoriasis, Quality of Life. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Pustular psoriasis (PP) is an uncommon subtype of psoriasis with distinct genetic features and clinical phenotypes. Patients with PP tend to experience frequent flares and significant morbidity. This study aims to determine the clinical characteristics, co‐morbidities and treatment of PP patients in Malaysia. This was a cross‐sectional study of patients with PP notified to the Malaysian Psoriasis Registry (MPR) between January 2007 and December 2018. Of 21 735 psoriasis patients, 148 (0.7%) had pustular psoriasis. Of these, 93 (62.8%) were diagnosed with generalized pustular psoriasis (GPP) and 55 (37.2%) with localized PP (LPP). The mean age for pustular psoriasis onset was 31.71 ± 18.33 years with a male to female ratio of 1:2.1. Patients with PP were more likely to have dyslipidaemia (23.6% vs. 16.5%, p = 0.022), severe disease (Body surface area >10 and/or Dermatology Life Quality Index [DLQI] >10) (64.8% vs. 50%, p = 0.003) and require systemic therapy (51.4% vs. 13.9%, p < 0.001) compared to non‐PP patients. Patients with PP also suffered greater impairment to their quality of life (DLQI >10, 48.9% vs. 40.3%, p = 0.046), had more days off school/work (2.06 ± 6.09 vs. 0.5 ± 4.91, p = 0.004) and a higher mean number of hospitalizations (0.31 ± 0.95 vs. 0.05 ± 1.22, p = 0.001) in 6 months compared to non‐PP patients. Overall, 0.7% of psoriasis patients in the MPR had pustular psoriasis. Patients with PP had a higher rate of dyslipidaemia, severe disease, greater impairment of quality of life and systemic therapy usage compared to other psoriasis subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hospital Queen Elizabeth, Ministry of Health Malaysia, Kota Kinabalu, Malaysia.
- Department of Dermatology, Hospital Kuala Lumpur, Ministry of Health Malaysia, Kuala Lumpur, Malaysia.
ORCID-Profile: Xin Yun Teoh, Robinson Suganthy
Zitieren
APA
Teoh, X. Y., Suganthy, R., Voo, S. Y. M., Tang, M. M., & Malaysian Psoriasis Registry Working Group (2023). Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018. Experimental Dermatology. https://doi.org/10.1111/exd.14770
Vancouver
Teoh XY, Suganthy R, Voo SYM, Tang MM, Malaysian Psoriasis Registry Working Group. Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018. Experimental Dermatology. 2023. doi:10.1111/exd.14770
BibTeX
@article{Teoh2023,
author = {Teoh, Xin Yun and Suganthy, Robinson and Voo, Sook Yee Michelle and Tang, Min Moon and Malaysian Psoriasis Registry Working Group, Malaysian Psoriasis Registry Working Group},
title = {Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018},
journal = {Experimental Dermatology},
year = {2023},
doi = {10.1111/exd.14770}
}
EUVIMED